Project profile — Polio Eradication Program



Overview 

CA-3-A035485001
$18,000,000
WHO - World Health Organization (41143)
2012-12-24 - 2015-03-30
Closed
Global Affairs Canada
WGM Africa

Country / region 

• Nigeria (100.00%)

Sector 

• Basic Health: Infectious disease control (12250) (100.00%)

Policy marker 

• Gender equality (significant objective)
• Environmental sustainability (cross-cutting) (significant objective)
• Participatory development and good governance (not targeted)
• Trade development (not targeted)
• Biodiversity (not targeted)
• Climate change mitigation (not targeted)
• Climate Change Adaptation (not targeted)
• Urban issues (not targeted)
• Desertification (not targeted)
• Children's issues (significant objective)
• Youth Issues (not targeted)
• Indigenous Issues (not targeted)
• Disability (not targeted)
• ICT as a tool for development (not targeted)

Description 

The goal of this project is to establish a more effective system for providing vaccinations in Nigeria and to increase the number of children under five who receive the polio vaccine. Nigeria is one of three countries in the world where children can still contract polio. Children under the age of five are the most at risk for polio infections and the risk is highest in northern Nigeria. It is estimated that 600,000 Nigerian children under five have never received a single dose of the polio vaccine. This project contributes to increasing the percentage of children under five who receive a full complement of vaccinations, including the polio vaccine, from 23% to 85% by 2015. This project supports the polio immunization activities of the Global Polio Eradication Initiative in Nigeria. Polio vaccination campaigns occur regularly throughout Nigeria both at the national level and at the state level, in areas where there is a higher rate of polio infections. The polio vaccination campaigns are also used as a platform for delivering other essential health services, such as routine vaccinations against common preventable diseases and health education. In addition, the project works with political, traditional, and religious leaders in Nigeria to build momentum toward greater community acceptance of polio immunization. The WHO is responsible for technical assistance, training, post-immunization campaign assessment surveys, data analysis, and report writing. The WHO also coordinates research, provides technical and operational support to the Federal and State Ministries of Health, and coordinates the training and deployment of human resources.

Expected results 

The expected intermediate results for this project include: (1) increased detection of polio cases and response to common communicable diseases; (2) increased and sustained immunity of target groups against wild polio transmission in all districts of the twelve highest risk states; and (3) increased protection of Nigerians with routine immunization against common preventable diseases, including polio.

Results achieved 

Results achieved as of the end of the project (March 2015) include: (1) Nigeria has made tremendous progress towards the interruption of wild poliovirus during this past year; (2) the percentage of 0-59 month-old children reached by oral polio vaccine (OPV) during supplemental immunization activities (SIAs) has increased from 81% in January 2014 to 96% by February 2015; (3) Global Affairs Canada contributed, along with other development partners, in reaching 6,226,104 children (about 91% of the target population) with polio vaccination in 12 states. This in turn has contributed to the reduction of the number of wild polio virus cases reported in Nigeria from 37 cases in 2013-2014 to five cases in 2014-15; (4) improving results from Lot Quality Assurance Sampling (LQAS) processes was demonstrated. Following the completion of the Immunization Plus Days (IPDs), the LQAS demonstrated that Nigeria’s quality assurance targets were exceeded in every IPD since January 2014; and (5) through ongoing data analysis in the Emergency Operations Centres (state and national), the program has developed strategic plans to address the identified challenges that prevent children from receiving oral polio vaccine (OPV). Canada has played a unique role in the coordination of the donor group for polio, which assists in ensuring policy coherence and the communication of program and funding issues.

Budget and spending 


Original budget $2,000,000
Planned disbursement $0
Transactions
Transaction Date Type Value
24-09-2014 Disbursement $2,000,000
Country percentages by sector
Type of finance Aid grant excluding debt reorganisation
Collaboration type Bilateral
Type of aid Contributions to specific-purpose programmes and funds managed by implementing partners
Date modified: